TORRENT PHARMA INC — Nystatin Importer Profile
Pharmaceutical Importer · #3 buyer for Nystatin · $4.4M import value · 162 shipments · UNITED STATES · DGFT Verified
TORRENT PHARMA INC is the #3 importer of Nystatin from India with $4.4M in import value and 162 verified shipments. TORRENT PHARMA INC holds a 8.6% market share in Nystatin imports based in UNITED STATES. The company sources from 1 verified supplier across 54 formulations shipped to 1 country. Overall, TORRENT PHARMA INC imports 9 pharmaceutical products worth $41.5M across 6 therapeutic categories.
TORRENT PHARMA INC — Nystatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Nystatin to TORRENT PHARMA INC?
Verified from 162 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TORRENT PHARMACEUTICALS LIMITED | $4.4M | 162 | 100.0% |
TORRENT PHARMA INC sources Nystatin from 1 verified Indian supplier based on 162 customs records. The primary supplier is TORRENT PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does TORRENT PHARMA INC Compare to Nearest Nystatin Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | EVERSANA LIFE SCIENCE SERVICES | UNITED STATES | $6.7M | 195 | $34.4K |
| 3 | TORRENT PHARMA INC ★ | UNITED STATES | $4.5M | 143 | $31.4K |
| 4 | LEADING PHARMA LLC | UNITED STATES | $3.5M | 69 | $50.0K |
| 7 | EVERSANA LIFE SCIENCE SERVICES.. | UNITED STATES | $1.3M | 30 | $42.1K |
TORRENT PHARMA INC ranks #3 among 458 Nystatin importers from India. Average shipment value of $31.4K compared to the market average of $45.4K. The closest competitors by value are EVERSANA LIFE SCIENCE SERVICES and LEADING PHARMA LLC.
Where Does TORRENT PHARMA INC Import Nystatin To?
Destination countries from 162 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $4.4M | 162 | 100.0% |
TORRENT PHARMA INC imports Nystatin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $4.4M.
What Nystatin Formulations Does TORRENT PHARMA INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| OTHER-NYSTATIN CREAM USP 100000 UN/G, 30 | $487.0K | 14 |
| OTHER - NYSTATIN CREAM USP, 100000 UN/G,30G US (NDC 13668-595-02) ( NYSTATIN CREAM 30G ) NOS SIZE 30G | $406.2K | 10 |
| OTHER-NYSTATIN CREAM USP 100000 UN/G 30G | $257.6K | 7 |
| OTHER - NYSTATIN CREAM USP 100000 UN/G30G US NDC 13668-595-02 NYSTATIN CREAM 30G NOS SIZE 30 G | $247.8K | 6 |
| OTHER - NYSTATIN CREAM USP 100000 UN/G,30G, US (NDC 13668-595-02) ( NYSTATIN CREAM 30G ) NOS SIZE 30G | $216.2K | 17 |
| NYSTATIN CREAM USP 100000 UN G 30G US NDC 13668 595 02 NYSTATIN CREAM 30G NOS SIZE 30 G | $192.5K | 8 |
| OTHER - NYSTATIN CREAM USP, 100000 UNITS/GM, 30GM (30GM TUBE) US (NDC 13668-595-02) ( NYSTATIN CREAM 30G ) NOS SIZE 30G | $168.9K | 4 |
| NYSTATIN CREAM USP 100000 UN/G, 30G, USNDC 13668-595-02 NYSTATIN CREAM 30G NOS=30 G | $146.1K | 5 |
| NYSTATIN CREAM USP 100000 UN/G, 30G, US | $139.5K | 4 |
| NYSTATIN CREAM USP 100000 UN G 30G US NDC 13668 595 02 NYSTATIN CREAM 30G NOS SIZE 30G | $137.6K | 3 |
TORRENT PHARMA INC imports 54 distinct Nystatin formulations from India. The top formulation is OTHER-NYSTATIN CREAM USP 100000 UN/G, 30 with 14 shipments worth $487.0K.
Regulatory Requirements: Importing Nystatin into United States
What TORRENT PHARMA INC and other importers must comply with to import Nystatin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Nystatin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Nystatin from India and How Much Does TORRENT PHARMA INC Import?
India exported $20.8M worth of Nystatin through 2,442 shipments from 223 suppliers to 96 countries, serving 458 buyers globally. TORRENT PHARMA INC imports $4.4M of this total, accounting for 8.6% of India's Nystatin exports with 162 shipments from UNITED STATES. This is verified from 162 customs shipment records covering 54 distinct formulations.
What Is the Average Order Value for TORRENT PHARMA INC's Nystatin Imports?
TORRENT PHARMA INC's average Nystatin order value is $27.4K per consignment, based on 162 shipments totaling $4.4M. TORRENT PHARMA INC is based in UNITED STATES and ranks #3 among all Nystatin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Nystatin to TORRENT PHARMA INC?
TORRENT PHARMA INC sources Nystatin from 1 verified Indian supplier: TORRENT PHARMACEUTICALS LIMITED ($4.4M, 100.0%). This is based on 162 customs records.
How Does TORRENT PHARMA INC Compare to Other Nystatin Importers?
TORRENT PHARMA INC ranks #3 among 458 Nystatin importers from India with a 8.6% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($6.7M), TORRENT PHARMA INC ($4.5M), LEADING PHARMA LLC ($3.5M). TORRENT PHARMA INC processed 162 shipments from UNITED STATES.
About TORRENT PHARMA INC
TORRENT PHARMA INC imports 9 products worth $41.5M. Beyond Nystatin, top products include Pantoprazole, Citalopram, Isosorbide, Rosuvastatin, Escitalopram. View the complete TORRENT PHARMA INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Nystatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Nystatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: TORRENT PHARMA INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as TORRENT PHARMA INC's capped import value divided by total capped export value for Nystatin across all Indian exporters.
- 5.Verified Records: This page is backed by 162 individual customs records matching TORRENT PHARMA INC importing Nystatin, covering 54 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 96+ countries, 458+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Nystatin Import Data for TORRENT PHARMA INC
Access order-level details, pricing data, supplier connections, and competitive analysis for TORRENT PHARMA INC's Nystatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
TORRENT PHARMA INC
Full Company Profile →
9 products · $41.5M total trade · 6 categories
TORRENT PHARMA INC × Nystatin
Verified from customs records
Company Overview
Top Products by TORRENT PHARMA INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for TORRENT PHARMA INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nystatin. For current order-level data, contact TransData Nexus.